No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia

Gynecologic and Obstetric Investigation

Volumn 62, Issue 1, 2006, Pages 7-13

  Siroen, Michiel P C ^a   Teerlink, Tom ^a   Bolte, Antoinette C ^a   Van Elburg, Ruurd M ^a   Richir, Milan C ^a   Nijveldt, Robert J ^a   Van Der Hoven, Ben ^b   Van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Placenta; Preeclampsia

Indexed keywords

DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; PLACENTA ENZYME;

ADULT; AMINO ACID METABOLISM; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LABOR STAGE 1; LIVER DYSFUNCTION; LIVER FUNCTION; PARAMETER; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ADULT; AMIDOHYDROLASES; CASE-CONTROL STUDIES; FEMALE; HELLP SYNDROME; HUMANS; NETHERLANDS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 33745727889     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091752     Document Type: Article

References (27)

1. Buhimschi IA, Saade GR, Chwalisz K, Garfield RE: The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum Reprod Update 1998;4:25-42.
2. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS: Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242-243.
3. Pettersson A, Hedner T, Milsom I: Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998;77:808-813.
4. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, Wennergren M, Hagberg H: Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001;80:602-608.
5. Holden DP, Fickling SA, Whitley GS, Nussey SS: Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1998;178:551-556.
6. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361:1511-1517.
7. Leiper JM, Santa MJ, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999;343:209-214.
8. Tran CT, Fox MF, Vallance P, Leiper JM: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 2000;68:101-105.
9. Maeda T, Yoshimura T, Okamura H: Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Investig 2003;10:2-4.
10. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA: Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002;303:131-137.
11. Teerlink T, van Leeuwen PA, Houdijk A: Plasma amino acids determined by liquid chromatography within 17 minutes. Clin Chem 1994;40:245-249.
12. López-Jaramillo P, Narvaez M, Calle A, Rivera J, Jacome P, Ruano C, Nava E: Cyclic guanosine 3′,5′ monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 1996;103:33-38.
13. Maas R, Böger RH, Schwedhelm E, Casas JP, López-Jaramillo P, Serrano N, Diaz LA: Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. JAMA 2004;291:823-824.
14. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P: Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003;23:1455-1459.
15. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA: The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 2003;22:17-22.
16. Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA: The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 2004;41:559-565.
17. Nijveldt RJ, Teerlink T, van Leeuwen PA: The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003;22:99-104.
18. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP: Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 2001;37:1191-1195.
19. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, Simmons RL: Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992;20:1568-1574.
20. Di Iorio R, Marinoni E, Emiliani S, Villaccio B, Cosmi EV: Nitric oxide in preeclampsia: lack of evidence for decreased production. Eur J Obstet Gynecol Reprod Biol 1998;76:65-70.
21. Nasiell J, Nisell H, Blanck A, Lunell NO, Faxen M: Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia. Acta Obstet Gynecol Scand 1998;77:492-496.
22. Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G: L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004;43:614-622.
23. Poranen AK, Aubry J, Kujari H, Ekblad U: Expression of nitric oxide synthase in normal and preeclamptic placental tissue and effects of glyceryl trinitrate and shear stress on placental blood flow. Acta Obstet Gynecol Scand 1998;77:594-597.
24. Conrad KP, Davis AK: Nitric oxide synthase activity in placentae from women with pre-eclampsia. Placenta 1995;16:691-699.
25. Lee CN, Chang SW, Cho NH, Cho SH: Nitrous oxide synthase expression in placenta of pre-eclampsia. J Korean Med Sci 1997;12:532-538.
26. King RG, Di Iulio JL, Gude NM, Brennecke SP: Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae. Reprod Fertil Dev 1995;7:1581-1584.
27. Laussmann T, Janosi RA, Fingas CD, Schlieper GR, Schlack W, Schrader J, Decking UK: Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow. FASEB J 2002;16:628-630.